{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T15:26:56Z","timestamp":1788622016377,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.ejphar.2005.09.004","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T12:48:02Z","timestamp":1131022082000},"page":"149-154","source":"Crossref","is-referenced-by-count":26,"title":["The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice"],"prefix":"10.1016","volume":"524","author":[{"given":"Tadafumi","family":"Tamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ohmori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2005.09.004_bib1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0091-6749(98)70256-8","article-title":"Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis","volume":"101","author":"Abdelaziz","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib2","doi-asserted-by":"crossref","first-page":"C1871","DOI":"10.1152\/ajpcell.2001.281.6.C1871","article-title":"Mechanisms of modulation of neuronal nicotinic receptors by substance P and OAG","volume":"281","author":"Andoh","year":"2001","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib3","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archderm.128.11.1509","article-title":"Immune dysregulation in atopic eczema","volume":"128","author":"Bos","year":"1992","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib4","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1046\/j.1365-2133.1998.02500.x","article-title":"Expression of nerve growth factor receptors in cutaneous inflammation","volume":"139","author":"Bull","year":"1998","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib5","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1046\/j.0022-202x.2001.01498.x","article-title":"The neurosensory tachykinins substance P and neurokinin A directly induce keratinocyte nerve growth factor","volume":"117","author":"Burbach","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S1081-1206(10)62513-6","article-title":"Olopatadine inhibits TNF\u03b1 release from human conjunctival mast cells","volume":"84","author":"Cook","year":"2000","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib7","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jaci.2004.07.054","article-title":"H1 histamine receptor mediates inflammatory responses in human keratinocytes","volume":"114","author":"Giustizieri","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0140-6736(94)90879-6","article-title":"Lesional expression of interferon-gamma in atopic eczema","volume":"343","author":"Grewe","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2005.09.004_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0167-5699(98)01285-7","article-title":"A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis","volume":"19","author":"Grewe","year":"1998","journal-title":"Immunol. Today"},{"key":"10.1016\/j.ejphar.2005.09.004_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1254\/jjp.87.167","article-title":"Effects of olopatadine hydrochloride on the cutaneous vascular hyperpermeability and the scratching behavior induced by poly-l-arginine in rats","volume":"87","author":"Hayashi","year":"2001","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2133.1994.tb08522.x","article-title":"Mast cells are one major source of interleukin-4 in atopic dermatitis","volume":"131","author":"Horsmanheimo","year":"1994","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/194589240201600108","article-title":"Cetirizine decreases interleukin-4, interleukin-5, and interferon-\u03b3 gene expressions in nasal-associated lymphoid tissue of sensitized mice","volume":"16","author":"Jin","year":"2002","journal-title":"Am. J. Rhinol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1084\/jem.173.3.775","article-title":"Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte\/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects","volume":"173","author":"Kay","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2005.09.004_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s004410000202","article-title":"Increase in NGF content and nerve fiber sprouting in human allergic contact eczema","volume":"302","author":"Kinkelin","year":"2000","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejphar.2005.09.004_bib15","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.4049\/jimmunol.159.5.2484","article-title":"Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile","volume":"159","author":"Kitagaki","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib16","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/S0091-6749(99)70052-7","article-title":"Itching and the atopic skin","volume":"104","author":"Koblenzer","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1440-1592.2004.00324.x","article-title":"Effects of neuropeptides in the development of the atopic dermatitis of mouse models","volume":"53","author":"Kojima","year":"2004","journal-title":"Allergol. Intern."},{"key":"10.1016\/j.ejphar.2005.09.004_bib18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1034\/j.1600-0625.2000.009002118.x","article-title":"Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists","volume":"9","author":"Lippert","year":"2000","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bcp.2004.10.006","article-title":"Histamine H1 receptor antagonist blocks histamine-induced proinflammatory cytokine production through inhibition of Ca2+-dependent protein kinase C, Raf\/MEK\/ERK and IKK\/I\u03baB\/NF-\u03baB signal cascades","volume":"69","author":"Matsubara","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1254\/jjp.88.379","article-title":"Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug","volume":"88","author":"Ohmori","year":"2002","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib21","first-page":"85","article-title":"Nerve growth factor and keratinocytes: a role in psoriasis","volume":"10","author":"Pincelli","year":"2000","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib22","first-page":"299","article-title":"Cutaneous innervation and the role of neuronal peptides in cutaneous inflammation: a minireview","volume":"8","author":"Rossi","year":"1998","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0625.1998.tb00307.x","article-title":"Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems","volume":"7","author":"Scholzen","year":"1998","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib24","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1001\/archderm.139.11.1463","article-title":"Neurophysiology of pruritus: cutaneous elicitation of itch","volume":"139","author":"Stander","year":"2003","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib25","article-title":"Evaluation of olopatadine using histamine H1 receptor-deficient mice","volume":"52","author":"Sugimoto","year":"2003","journal-title":"Jpn. J. Allergol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib26","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1365-2133.2004.06172.x","article-title":"Effects of olopatadine hydrochloride, an antihistamine drug, on skin inflammation induced by repeated topical application of oxazolone in mice","volume":"151","author":"Tamura","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2133.2002.04803.x","article-title":"Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis","volume":"147","author":"Toyoda","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib28","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1046\/j.1365-2222.2003.01719.x","article-title":"Localization and content of nerve growth factor in peripheral blood eosinophils of atopic dermatitis patients","volume":"33","author":"Toyoda","year":"2003","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.ejphar.2005.09.004_bib29","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0923-1811(00)00138-9","article-title":"Cytokines and chemokines in the epidermis","volume":"24","author":"Uchi","year":"2000","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ejphar.2005.09.004_bib30","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/archopht.117.5.643","article-title":"Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs","volume":"117","author":"Yanni","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib31","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1346-8138.1999.tb02090.x","article-title":"Itch and atopic dermatitis: an overview","volume":"26","author":"Wahlgren","year":"1999","journal-title":"J. Dermatol."},{"key":"10.1016\/j.ejphar.2005.09.004_bib32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1523-1747.1998.00239.x","article-title":"Intralesional cytokines in chronic oxazolone-induced contact sensitivity suggest roles for tumor necrosis factor \u03b1 and interleukin-4","volume":"111","author":"Webb","year":"1998","journal-title":"J. Invest. Dermatol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905009106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905009106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T11:36:28Z","timestamp":1706700988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299905009106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":32,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0014299905009106"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2005.09.004","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}